Risendronic Acid ATC: M05BA07 Therapeutic Area: Musculoskeletal system Therapeutic Indications: Osteolysis 4 tabs 35 mg / Shelf: 36 months / Batch: 13000 units Request for more information Name*Company*Email* PhoneMessage*Privacy* I agree to the Privacy Policy
